AXIM Develops Quantitative Rapid Diagnostic Test for Lacritin; Now Boasts Four Dry Eye Disease Point-of-Care Biomarker Tests
April 27, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting Dry Eye...
100% of Husson University Clinical Mental Health Counseling Students Pass the National Counselor Examination on their First Attempt
March 22, 2022 08:10 ET
|
Husson University
BANGOR, MAINE, March 22, 2022 (GLOBE NEWSWIRE) -- Husson University announced today that 100% of their clinical mental health counseling students recently passed their National Counselor...
NATIONALLY RANKED ROSEN LAW FIRM Encourages Talis Biomedical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – TLIS
January 14, 2022 15:35 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 14, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
Kepler Communications Announces Testing of ÆTHER™ Network with Spire Global, Inc.
December 16, 2021 09:00 ET
|
Kepler Communications
Toronto, Ontario, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Kepler Communications announced today the signing of a contract with Spire Global, Inc. (“Spire”) (NYSE: SPIR), a leading global provider of...
AXIM Biotechnologies’ Development of Rapid Test for COVID-19 Neutralizing Antibodies is Cited to Demonstrate over 90% Sensitivity and 100% Specificity
November 09, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19...
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reconnaissance Energy Africa Ltd. f/k/a Lund Enterprises Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – RECAF, LGDOF
October 28, 2021 09:36 ET
|
The Rosen Law Firm PA
NEW YORK, Oct. 28, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
AXIM® Biotechnologies Develops Next Generation of its Rapid Neutralizing Antibody Test for COVID-19
October 12, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological,...
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Amended Emergency Use Authorization with FDA for its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations
August 30, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting...
Biozek Medical Launches Non-Invasive Oral Fluid COVID-19 (Saliva) Antigen Rapid Test to Combat "Nasal Swab Fatigue" and Mutating Variants
August 04, 2021 17:22 ET
|
Biozek Medical
Apeldoorn, Netherlands, Aug. 04, 2021 (GLOBE NEWSWIRE) -- As businesses look for ways to remain safely open, Biozek Medical announced the launch of their new COVID-19 Antigen Saliva Rapid test, a...
Global Genetic Toxicology Testing Market is Estimated to Grow at a CAGR of 10.0% from 2021 to 2030
July 05, 2021 06:00 ET
|
Quince Market Insights
Pune, India, July 05, 2021 (GLOBE NEWSWIRE) -- The global genetic toxicology testing market is estimated to value at USD 1.90 billion in 2021 and is expected to grow at a CAGR of 10.0%. Market...